Tender Summary

Nucleic Acid Testing Services

Buying Organisation

NHS Blood and Transplant

Contract Value

£50,000,000

Tender Description

NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below.
All in vitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. The intended use of the assays must include use on human blood, stem cell, and tissue donors.
Great Britain (GB) will continue to recognise CE marking under the IVDD or IVDR until devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) without the need for changes to PULSE. NHSBT are looking for a fully integrated, high throughput, automated Nucleic Acid Testing (NAT) screening system which can detect HCV RNA, HIV-1 RNA, HIV-2 RNA, HBV DNA, HEV RNA, and WNV RNA.
NAT Screening will be performed by NHSBTs two testing sites in England at Manchester and Bristol (Filton). Samples from blood donors donations will be pooled prior to screening therefore pooling equipment is also required as part of the solution. Samples from stem cell and living tissue donors will be screened as individual donations and therefore not pooled.
Throughput requirements:

HCV RNA, HIV-1 RNA, HIV-2 RNA, HBV DNA, HEV RNA: 1,520,000 samples per year
WNV RNA: 48,000 samples per year
At a minimum, HCV, HIV, and HBV must be multiplexed

KEG approval is a mandatory requirement for this opportunity, in-line with the requirements of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).NHSBT will seek to understand the status of assays which would be offered with regards to KEG within the Tender.

Tender categories (products & services required)

Diagnostics and radiodiagnostic devices and supplies (CPV 33124000)
Laboratory services (CPV 71900000)
Automation system (CPV 48921000)
Blood-testing reagents (CPV 33696200)
Diagnostic kits (CPV 33141625)
Laboratory reagents (CPV 33696500)
Diagnostic systems (CPV 33124110)

Region

North East (UKC)

Buyer Information

NHS Blood and Transplant

  Further information on this tender from NHS Blood and Transplant when you create a FREE Account

Other tenders you might like

You have more tenders waiting!

View all of your tenders, see forthcoming opportunities, access data/reports.